Hematopoietic neoplasms in the rodent may be classified into lymphoid or nonlymphoid neoplasms. Lymphoid neoplasms include the following morphologic types: follicular center cell, lymphoblast (lymphocytic), immunoblast, plasma cell, and large granular lymphocyte (LGL). Nonlymphoid hematopoietic neoplasms include histiocytic sarcoma, granulocytic leukemia, erythroid leukemia, and mast cell tumors. Most types of hematopoietic neoplasms, exclusive of LGL lymphoma (leukemia), are more common in mice than in rats. Specific strains of mice have a hematopoietic tumor incidence of more than 50% in aged animals. Some strains of rats (i.e., Fischer-344) may have an incidence of over 50% of LGL lymphoma in aged animals. The tumor type and incidence are characteristic for each rat or mouse strain. Hematopoietic neoplasms have been better characterized immunomorphologically in mice than in rats. The specific cell type and tissue of origin for hematopoietic neoplasms may be important for safety evaluation of chemicals. Specific chemicals may induce specific types of these tumors, which may be the same or different from the spontaneous types. Lymphoid cell neoplasms should not be grouped with nonlymphoid neoplasms in determining the toxicity and carcinogenicity of test substances.
INTRODUCTION
Because the mouse and the rat are extremely valuable experimental model systems that are widely used in biomedical and toxicological research, it is of importance to define and characterize the morphology, immunocytochemistry, and incidence of hematopoietic disease in these mammalian species. Previously, the mouse has been shown to be an excellent immunomorphologic model for human B-cell lymphoproliferative disease (21, 3 9, 40) , but the rat has been studied to a lesser extent due to its lower incidence of most hematopoietic neoplasms.
Additional incentive comes from the fact that rodent species are more experimentally accessible than the human and, furthermore, allow for better controlled prospective studies involving large numbers of genetically uniform animals. The purpose of this report is to present the morphology, immunocyto-chemistry, and incidence of hematopoietic neoplasms in common strains of rats and mice. Table I is a morphologic classification system for hematopoietic neoplasms in rodents modified from Frith et al (24) . Table II is an immunomorphologic classification of hematopoietic neoplasms in the rodent modified from Pattengale and Frith (39) . For morphologic and immunocytochemical purposes, hematopoietic neoplasms can be divided into lymphoid and nonlymphoid neoplasms. Lymphoma types include lymphoblastic, follicular center cell (FCC), plasma cell, immunoblastic, and large granular lymphocyte (LGL). Nonlymphoid hematopoietic neoplasms include tumors of histiocytic, granulocytic and mast cells.
MORPHOLOGY AND IMMUNOCYTOCHEMISTRY

Lymphomas
FCC Lymphoma (Mixed or Pleomorphic Lymphoma). FCC lymphoma is well characterized in Modified from Frith CH, Ward JM, Brown RH, Tyler RD, Chandra M, and Stromberg PC (1992) . Proliferative lesions of the hematopoietic system in rats. In: Guides for Toxicologic Pathology. STP/ARP/AFIP, Washington, D.C. the mouse but not in the rat (18) . They have been referred to as reticulum cell sarcoma, type B in the mouse (14) , as well as pleomorphic or mixed cell lymphoma in the mouse (25) and reticulum cell sarcoma in the rat. The disease is rare before 12 mo of age except in a few strains and may increase dramatically in some mouse strains after 18 mo. More recent research in mice and humans indicates the FCC lymphoma originates from B lymphocytes or FCCs (21, 39, 40) . In the mouse, the spleen, mesenteric lymph nodes, and Peyer's patches of the ileum are the most commonly involved sites. Neoplastic cells may be predominantly large, small, or a mixture of large and small cells. Tumor cells are cohesive, and the cytoplasm usually is more abundant in larger cells. Nuclei may be cleaved or noncleaved (Figs. 1 and 2). Larger cells tend to have vesicular nuclei with prominent nucleoli, and the mitotic index generally is low. Tumor cells contain immunoglobulins that can be demonstrated by immunocytochemistry of frozen or fixed tissue sections ( Fig. 3 ). Tissues fixed in B-5, Zenkers, or Bouin's solution are optimum for demonstrating immunoglobulins (21, 5 7, 5 9) . Plasma Cell Lymphoma. Neoplastic cells are small to large and noncohesive with abundant amphophilic cytoplasm. Nuclei are round to oval and have irregularly marginated condensed chromatin. Mitotic activity is variable. Spontaneous plasma cell lymphomas are uncommon, but intraperitoneal plasma cell tumors can be induced in mice with intraperitoneal injections of mineral oil. pattern of organ involvement is similar to that of FCC lymphoma, but immunoblastic lymphoma usually is more invasive. In the European LOU rat, these tumors arise from Peyer's patches of the ileocecal junction (42) . In mice, intraperitoneally injected hybridoma cells produce an immunoblastic lymphoma ( Fig. 4 ).
Lymphoblastic (Lymphocytic) Lymphoma. Lymphoblastic (lymphocytic) lymphoma is very common in some strains of mice and is more common than FCC lymphoma in the rat, but it is also relatively rare in the rat (4) (5) (6) (7) 18) . Neoplastic cells vary in size but tend to be uniform and noncohesive.
Cytoplasm is scant, and nuclei are round and often contain multiple and prominent nucleoli (Fig. 5 ). Mitotic index is intermediate to high. Spleen, liver, lymph nodes, thymus, bone marrow, and kidneys are commonly involved, and leukemia often occurs. Lymphoblastic lymphoma may arise from the thymus of rats or mice after exposure to retroviruses or chemical carcinogens (33, 34) .
This disease is one of the more common hematopoietic neoplasms in mice and may occur as early as 1 mo of age (T-cell lymphoblastic). It may develop from either T or B lymphocytes, is often spontaneous, or can be induced by retroviruses, chemicals, or irradiation. The incidence of lymphoblastic lymphoma usually increases slightly in all strains with age and, at 3-6 mo, may have a slight peak (Tlymphoblastic) in some strains such as the BALB/c x 630. and a major peak in AKR mice. The incidence is generally higher in female mice.
LGL Lymphoma (Leukemia). LGL lymphoma (leukemia) is very common in some strains of rats (e.g., Fischer-344 [F-344], Wistar/Furth) (50, 51, 57, 61) , but it is much less common in other strains (e.g., Sprague-Dawley) (18) and has not been reported in the mouse. Clinically, the disease is char-acterized by depression, weight loss, pallor, icterus, splenomegaly, hemolytic anemia, and tumor cell erythrophagocytosis (46, 49) . The disease was initially characterized as mononuclear cell leukemia (46, 50, 61) . Neoplastic cells are small but pleomorphic with nuclei that are irregular or reniform in some cases, round in others, and often eccentrically located in the cell (48) . Small nucleoli are oc-casionally visible (Fig. 6 ). Tumor cells are OX-8 immunoreactive, or the cell membrane and antibodies to granule antigens such as cytolysin can be used to demonstrate granules in paraffin sections (60) . Tumor cells contain a small amount of cytoplasm with sparse nuclear chromatin. Usually, neoplastic cells containing pink to red or red-purple cytoplasmic granules are present in Romanovskistained peripheral blood smears and imprints of enlarged spleen or lymph nodes, but granules are not visible in hematoxylin and eosin-stained fixed tissue sections. Ultrastructurally, the granules are readily visible in some, but not in all, neoplastic cells, and nuclei are round with uniform or irregular nuclear membranes, coarsely clumped and marginated chromatin, and, often, a single nucleolus (49, 50) . In F-344 rats, the disease appears to originate in the marginal zone of the spleen and rapidly spreads to other organs (37) . Liver involvement ranges from a small number of isolated leukemic cells in the sinusoids in early cases to large accumulations of neoplastic cells resembling lymphoblastic lymphoma in more advanced cases. Leukemia is a common feature.
The disease can be staged or graded (stages 1-3) depending on its severity (16, 37, 46) . In stage 1, the spleen is normal in size or only slightly enlarged with increased numbers of neoplastic LGLs in the red pulp and marginal zone; no or very few neoplastic cells are found in the liver sinusoids, and no identifiable neoplastic cells are found in other organs. In stage 2, the spleen is moderately enlarged with moderate to large numbers of LGLs in the red pulp; architectural features including lymphoid follicles and periarteriolar lymphocytic sheaths remain intact; there is minimal to moderate involvement of the liver; and neoplastic cells may be evident in blood vessels in other organs, but aggregates/masses of neoplastic cells generally are limited to the spleen, liver, and lung. In stage 3, the disease is advanced with multiple organ involvement, the spleen is usually markedly enlarged with enactment of the normal architectural features by infiltrations of neoplastic cells, the liver is moderately to markedly enlarged and nodular, the hepatic parenchyma shows variable degenerative changes associated with the accumulation of neoplastic cells, and there are accumulations of neoplastic cells in other organs including lung, lymph nodes, kidney, brain, and adrenal gland.
Tumors of the Mononuclear-Phagocyte S'ystem:
Histiocytic Sarcoma This neoplasm has been referred to as malignant fibrous histiocytoma (45, 58) and histiocytic sarcoma in the rat (1, 5, 7, 18, 44) and reticulum cell sarcoma type A (14) and histiocytic lymphoma and sarcoma in the mouse (4, 6, 19, 21, 23) . Other investigators have described the lesion as endometrial sarcoma (9, 11) or malignant schwannoma (47) . Research findings have suggested that the neoplastic cells are derived from histiocytic cells of uncertain origin (bone marrow cells, tissue histiocytes, Kupffer's cells, macrophages) (19) . Histiocytic sarcomas are rare before 12 mo of age in rats and mice and slightly more common in female mice than in male mice. The liver is the most commonly involved organ in male mice; in female mice, the uterus and vagina as well as the liver are often the primary site, suggesting these tissues as tissues of origin. Other organs less frequently involved include the spleen, lymph node, bone marrow, lung, kidney, and ovaries. Metastatic lesions to the lungs occur in a high percentage in both rats and mice with liver involvement. Cells are large and monomorphic with dark basophilic nuclei and prominent eosinophilic cytoplasm ( Fig. 7 ) that is positive for lysozyme and other mononuclear phagocyte antigens (59) . They lack Bor T-lymphocyte antigens. In the rat, the disease tends to be more fibrous in some tissues of some rats (44, 58, 60) , and palisading of cells is more prominent than in the mouse (Fig. 8) . Skin, subcutaneous tissue, and peritoneum are frequently involved and may be primary sites in rats. Induced tumors in the skin of rats are more fibrous and have been diagnosed as malignant fibrous histiocytomas (35) . Neoplastic cells tend to be more noncohesive in the liver and more cohesive in the subcutaneous tissue. Diffuse involvement of the liver often occurs, and multinucleated giant cells may be prominent. The disease may produce myeloid hyperplasia of the spleen and hyaline droplets in renal proximal tubules of rats and mice (28) . Multiple organs including kidneys, lymph nodes, bone marrow, and ovaries may be infiltrated. Neoplastic cells are immunoreactive for lysozyme, vimentin, and ED 1 (Fig. 9 ) in rats (13, 56) . Chen et al (8) described histiocytic sarcoma in a Mongolian gerbil.
Histiocytic cells are usually derived from the mononuclear-phagocyte system (MPS), which includes promonocytes, monocytes, tissue histiocytes, and macrophages (32, 55) . These cells are believed to be derived from bone marrow stem cells and to have various functional characteristics. A number of cellular transformations and proliferative disorders have been presumed to arise from the MPS. These disorders in humans are generally classified as either bone marrow-based (monocytic leukemia) or tissue-based (histiocytosis) (26) . There are two major categories for the tissue-based histiocytic malignancies : true histiocytic lymphoma (THL) and malignant histiocytosis (MH) (3, 10, 54, 63) . Recent investigations revealed that the tissue histiocytes and some macrophages, presumably still under the cell H&E.
x 250.
Fm. 8.-Histiocytic sarcoma in the rat showing fibrous areas with elongated histiocytes. H&E.
lineage of MPS, are specialized fibroblastic-type cells with potential phagocytic capability, and their pathways are not necessarily bone marrow stem cells but possibly of bone marrow periosteal fibroblast origin (63) . Conventional histiocytes in the spleen and bone marrow may be cells of fibroblastic origin called barrier cells (63) . Two histocytic malignancies (THL and MH) in humans may be derived from different types of histiocytes, from histiocytes in different stages of maturation or differentiation, or from histiocytes that have distinct mechanisms of tumorigenic transformation (31 ) . The diseases are not well understood, and the terminology applied in humans and animals is inconsistent.
Myelogenous Leukemia Granulocytic Leukemia. Neoplastic cells usually represent a single immature or mature develop- x 250. mental stage, but in some cases cells in various developmental stages may be seen. When immature cells predominate, cell may be large and blastic, and segmented or lobed nuclei may be scarce. The disease usually is leukemic and involves the liver, spleen, lymph nodes, and bone marrow. Kidney involvement appears to be common in the rat and less so in the mouse (30) . The disease is a rare spontaneous disease in both rats and mice. Neoplastic cells are immunoreactive for lysozyme (60) . Specific retroviruses can also cause this type of leukemia in mice, and some chemicals induce tumors in rats. Erythroid Leukemia. Erythroid leukemia (erythroleukemia) appears to be a rare entity in mice and rats. In mice, the majority of reported cases are associated with the experimental inoculation of either the Friend leukemia virus or the Rauscher virus (17) . However, erythroid leukemia may rarely occur x 250.
as a spontaneous disease in the mouse (20) . Bone marrow, thymus, spleen, liver, kidney, and lymph nodes contain cells of the erythrocytic series, many of which are erythroblastic in appearance.
Erythroid leukemia has not been described as a spontaneous lesion in the rat. The leukemia is characterized by an excessive proliferation of erythroblastic cells. The condition has been described in rats after radiation and trimethylbenz[a]anthracene exposure (52) .
Mast Cell Tumors
Mast cell tumors, including benign and malignant tumors (sarcomas) are also rare in mice but have been reported to occur as spontaneous lesions (12, 15, 22, 43) . One case of mast cell sarcoma was seen in an 18-mo-old C57BL/6 control female mouse, and a small number of cases have been observed in (22, 43) . The mast cells are usually disseminated (Figs. 10 and 11 ) and involve the skin, liver, spleen, and kidneys. Cytoplasmic granularity may not be evident but can be easily demonstrated with testing for metachromasia.
Thymoma
The term thymoma usually is used in the rat and mouse to classify a lesion characterized by a neoplastic epithelial component (Fig. 12 ) with or without neoplastic lymphocytes (7, 36) . The epithelial component appears to be derived from the epithelial cells in Hassall's corpuscles or thymic reticular tissue and may be a majority of the tumor mass or a minor component. Thymomas may assume either a carcinomatous (Fig. 13 ) or a sarcomatous appearance, but thymomas rarely metastasize. The epithelial component is often positive for keratin.
Murray et al (38) described the incidence, morphology, and ultrastructure of spontaneous thymomas in an inbred Wistar/Neuherberg strain of rats, a high incidence strain. These lesions were observed with an incidence of 97 and 36%, in females and males, respectively. The thymomas often caused dyspnea and were occasionally the direct cause of death. The neoplasms resembled human thymomas iviaies remaies Fm. 15.-Incidence of LGL lymphoma in F-344 rats. having a variable cell composition, ranging from lymphoid to epithelial cells.
INCIDENCE OF HEMATOPOIETIC NEOPLASMS
The incidence of rodent hematopoietic neoplasms varies markedly with the species and strain. Generally, the incidence of hematopoietic neoplasms is much higher in the mouse than in the rat, and the incidence is usually higher in female mice compared to male mice. LGL lymphoma (leukemia) in the rat is the exception because it can occur at a very high incidence in select strains of rats (i.e., F-344), but it has not been reported in the mouse.
Rats
One author (CHF) recently reviewed hematopoietic neoplasms in 6 chronic studies involving Spra- gue-Dawley rats (Charles River Cud@), which included a total of 1,765 male and 1,765 female rats (18) . The information is presented in Table III and Fig. 14. The incidence of all types of hematopoietic neoplasms was low. The lymphoid neoplasms, lymphoblastic lymphoma, and LGL lymphoma were found in the highest incidence. The nonlymphoid hematopoietic neoplasm with the highest incidence was histiocytic sarcoma.
The most common hematopoietic lymphoid neoplasm in the F-344 rat is LGL lymphoma, and the incidence may be above 50% in animals 2 yr or older. This highly lethal tumor can affect group survivability and therefore can potentially impair the reliability of tumor bioassays (50) . Other lymphomas, including lymphoblastic and follicular center cell types, are rare in the F-344 rat. The incidence of LGL lymphoma in other strains of rats is much higher. Frith (18) reported an incidence of 0.50% in both male and female Sprague-Dawley rats. The most common nonlymphoid hematopoietic neoplasm in the rat is histiocytic sarcoma. The in- (18) .
In the F-344 rat, all types of hematopoietic neoplasms occur at a very low incidence exclusive of LGL lymphoma. It is possible that >99% of all spontaneous F-344 lymphomas are of LGL origin. The incidence of LGL lymphoma (leukemia) can vary markedly in the F-344 rat between studies and laboratories (5, 29, 53) and can even vary among groups of 50-55 rats within the same study with the same pathologists (Table IV and Fig. 15 ). Both treated and control groups were included to illustrate the variation in the incidence of the disease in different groups. In the animals that died on study (DOS), the incidence ranged form 35 The distribution of LGL lymphoma can also vary markedly depending on the stage of the disease (Table V and Fig. 16 ). The spleen and liver were involved 100% in both male and female rats whenever
LGL lymphoma was diagnosed. The lung was the next most frequently involved organ (35.2% in males and 39.3% in females). The spinal cord was the least affected (2.2% in males and 1.8% in females). Organ involvement was generally similar between the two sexes, except the percentage was slightly higher in females for some of the organs (Table V) . Both the uterus and ovaries were involved in the females, but the testes were not involved in the male rats.
Mice
The incidence of hematopoietic neoplasms varies markedly in mice depending on the strain. Table VI and Figs. 17-21 illustrate the incidence of hematopoietic neoplasms in several selected strains of mice at various ages. The most common hematopoietic lymphoid neoplasm in the mouse is FCC lymphoma followed by lymphoblastic lymphoma. The highest incidence of FCC lymphoma (35.5%) occurred in BALB/c female mice older than 18 mo (Table VI and Fig. 17 ). The incidence was 19.7% in C57BL/6 females older than 18 mo (Table VI and Fig. 18 ).
The most common nonlymphoid hematopoietic neoplasm in the mouse is histiocytic sarcoma. The incidence in mice varies with the strain and stock. C57BL/6 female mice had an incidence of 4.0% (Table VI) , whereas SENCAR mice had 22% (62) . Granulocytic leukemia appears to be rare in the mouse and the rat and must be distinguished from myeloid metaplasia.
DISCUSSION
The terminology used to report the incidence of hematopoietic neoplasms in rodents is quite varied (2, 25, 27, 41). More consistency is needed for com- parison among studies and among laboratories. The overall incidence of hematopoietic neoplasms, exclusive of LGL lymphoma, is generally much lower in rats than in mice.
It is important to differentiate among the morphologic (and immunomorphologic) types of hematopoietic neoplasms in rodents for purposes of chemical safety evaluation. Each mouse or rat strain has its characteristic tumor types with specific organ origin and spread. If a chemical induces a lymphoma or leukemia, it often induces a specific immunomorphologic type, with specific sites of origin and metastases (thymic lymphoma metastasizing to many tissues). These induced tumors will frequently show different morphology, site of origin, and metastases than for spontaneous tumors. If the tumors resemble spontaneous tumors, it is important for their potential mechanism of induction. An example is given in Fig. 22 (34) . In this case, the carcinogen clearly induced a unique type of tumor not found in controls. If a chemical increases the incidence of spontaneous lymphoma or leukemia (e.g., LGL lymphoma in F-344 rats) (15) , it may be promoting the spontaneous tumor rather than inducing it.
In summary, the rodent is an extremely valuable animal model for use in biomedical and toxicological research. The specific type of hematopoietic neoplasm may be important, and lymphoid cell neoplasms should be classified separately from nonlymphoid cell neoplasms in determining the toxicity and carcinogenicity of test substances.
